Mohammad Hirmand
2020
In 2020, Mohammad Hirmand earned a total compensation of $690.4K as Chief Medical Officer at Turning Point Therapeutics, a 90% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $247,680 |
|---|---|
| Salary | $421,102 |
| Other | $21,592 |
| Total | $690,374 |
Hirmand received $421.1K in salary, accounting for 61% of the total pay in 2020.
Hirmand also received $247.7K in non-equity incentive plan and $21.6K in other compensation.
Rankings
In 2020, Mohammad Hirmand's compensation ranked 10,014th out of 13,090 executives tracked by ExecPay. In other words, Hirmand earned more than 23.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,014 out of 13,090 | 24th |
Division Manufacturing | 4,307 out of 5,618 | 23rd |
Major group Chemicals And Allied Products | 1,770 out of 2,251 | 21st |
Industry group Drugs | 1,548 out of 1,951 | 21st |
Industry Pharmaceutical Preparations | 1,141 out of 1,456 | 22nd |
Source: SEC filing on April 29, 2022.
Hirmand's colleagues
We found four more compensation records of executives who worked with Mohammad Hirmand at Turning Point Therapeutics in 2020.